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The pathogenesis of Type 2 highly pathogenic porcine reproductive and respiratory syndrome virus
(HP-PRRSV) in 10-week old swine in the United States was investigated. rJXwn06, rescued from an
infectious clone of Chinese HP-PRRSV, replicated in swine with at least 100-fold increased kinetics over
U.S. strain VR-2332 . rJXwn06 caused signiﬁcant weight loss, exacerbated disease due to bacterial sepsis
and more severe histopathological lung lesions in pigs exposed to HP-PRRSV than to those infected with
VR-2332 . Novel ﬁndings include identiﬁcation of bacterial species present, the degree of thymic atrophy
seen, and the inclusion of contact animals that highlighted the ability of HP-PRRSV to rapidly transmit
between animals. Furthermore, comprehensive detailed cytokine analysis of serum, bronchoalveolar
lavage ﬂuid, and tracheobronchial lymph node tissue homogenate revealed a striking elevation in levels
of cytokines associated with both innate and adaptive immunity in HP-PRRSV infected swine, and
showed that contact swine differed in the degree of cytokine response.
Published by Elsevier Inc.Introduction
In 2006, investigators from several Chinese provinces reported a
unique syndrome in growing swine that was highlighted by the
predominant clinical signs of high fever, anorexia, listlessness, red
discoloration of skin, respiratory distress and very high morbidity
and mortality rates (Li et al., 2007; Tian et al., 2007; Tong et al.,
2007; Wu et al., 2009; Zhou et al., 2008). Originally known as
porcine high fever disease (PHFD), this syndrome spread to Vietnam
in 2006 and to Cambodia, Laos, The Philippines, Bhutan, Myanmar,
Thailand, South Korea and Russia in later years (An et al., 2011; Feng
et al., 2008). Although there was concern that this syndrome may
have been caused by a new disease agent, extensive diagnostic
testing revealed only known pathogens. One consistent ﬁnding was
the detection of porcine reproductive and respiratory syndrome
virus (PRRSV) with two discontinuous deletions in the replicase
polyprotein known as nonstructural protein 2 (nsp2), and two singleInc.
h Service, Virus and Prion
isease Center, 1920 Dayton
aberg).nucleotide deletions in the 50 and 30 untranslated regions (UTRs)
(Zhou and Yang, 2010). Experimental infection of Chinese swine
with the initial novel PRRSV ﬁeld isolates reproduced the clinical
disease (Li et al., 2007; Tian et al., 2007; Tong et al., 2007; Wu et al.,
2009; Zhou et al., 2008), providing strong evidence for its role as the
causal agent of PHFD. Since the severity of the clinical disease was
greater than expected for a typical PRRSV infection, there remained
the chance that an unknown agent in the PRRSV isolates exacer-
bated the disease symptoms. This question was resolved when
PHFD was reproduced in Chinese swine with virus derived from an
infectious clone of the JX143 PRRSV isolate (Lv et al., 2008).
The prior studies demonstrated that PRRSV isolates with a
common genetic pattern had a causal role in PHFD, leading to the
new designation of this viral lineage as highly pathogenic PRRSV
(HP-PRRSV). The presence of the unique nsp2 deletion motif was
initially thought to contribute to the severity of disease (Tian et al.,
2007). However, studies showed that the nsp2 region of HP-PRRSV
strain rJXwn06 containing the novel deletion could be replaced
with 458 amino acids from low virulence strain HB-1/3.9 to result
in a chimeric virus with only a minor delay in mortality (Zhou et al.,
2009). There was also concern that there may be some unique
aspect that may predispose Asian pigs to a severe outcome, e.g.,
Fig. 1. Average daily weight gain (ADWG) of swine during the course of the study.
Shown are ADWG and associated standard errors for each of the four groups for
days 1–7 and days 7–13. Sham inoculated control swine (Group 1) and those
challenged with VR-2332 (Group 4) gained weight at an expected rate for their age
group. Group 2 swine challenged with HP-PRRSV strain rJXwn06 and their
contacts (Group 3) lost body weight during the last week of the experiment.
The ADWG for Group 2 on days 1–7 includes only 11 pigs, and on days 7–13
includes only 8 pigs. The body weights for the contact animals were taken on the
same day as pigs in the other groups. Signiﬁcance values are shown.
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climate, or host genetics. Although a number of experiments have
associated genetic changes in PRRSV with an attenuation pheno-
type using point mutations (Grebennikova et al., 2004; Nielsen
et al., 2001; Storgaard et al., 1999) or by the construction of
chimeric viruses (Ellingson et al., 2010; Kwon et al., 2008; Wang
et al., 2008; Zhou et al., 2009), there appears to be no single locus
for which mutations confer a predictable change in virulence.
Collectively, this area of study suggests the factors that contribute
to PRRSV pathogenicity are complex and viral strain-speciﬁc .
As part of the single-strand positive-sense RNA virus order
Nidovirales, family Arteriviridae, PRRSV genomes can vary between
15 kb to 15.5 kb, consist of at least 10 open reading frames (ORFs)
and replicate through a nested set of subgenomic RNAs (van
Hemert and Snijder, 2008). Members of this highly variable virus
have been grouped into two genotypes, Type 1 (European-like,
prototype strain Lelystad) or Type 2 (North American, prototype
strain VR-2332), which differ in nucleotide similarity by approxi-
mately 45% (Nelsen et al., 1999). Both genotypes have representa-
tives of varying pathogenicity, and intragenic nucleotide sequence
variation in each can be as much as 20% (Shi et al., 2010). For this
study, we imported a plasmid containing the cDNA copy of the HP-
PRRSV strain rJXwn06 genome, a Type 2 PRRSV genome that is
15,321 bases in length and has 89% pairwise nucleotide identity to
the prototype genome of VR-2332 (Zhou et al., 2009). To investi-
gate the pathogenesis of HP-PRRSV infection and the potential
contribution of climate, host genetics, commensal bacteria, other
environmental conditions and husbandry practices to the patho-
genicity of HP-PRRSV in U.S. swine, we compared and contrasted
the pathogenicity of rescued JXwn06 (rJXwn06) virus to that of VR-
2332 in 10-week old swine. We found that this HP-PRRSV strain
caused extreme morbidity, as was seen in Asia, but novel to this
study, resulted in up to 100x higher abundance of circulating virus
when compared to VR-2332, caused extremely exacerbated thymic
atrophy such that the thymus was often difﬁcult to discern, and the
host response was assessed in comparison to animals infected with
strain VR-2332 for the ﬁrst time by a swine protein array including
5 innate and 5 adaptive cytokines in serum, bronchoalveolar lavage
ﬂuid and lymph nodes. Moreover, we completed bacterial specia-
tion and loads after necropsy and speciﬁed the degree of weight
loss seen. Lastly, we showed that HP-PRRSV readily transmitted to
contact swine causing a different pattern of cytokine responses. As
a result of our study, the remaining plausible contributing factors
to the high virulence seen in Asia were discredited, and thus HP-
PRRSV strains pose a serious threat to the U.S. swine industry.Results
Swine study
Pigs challenged with Chinese HP-PRRSV strain rJXwn06 (Group 2)
began exhibiting clinical signs of disease within 2–3 days post
exposure (dpe). As a group, the pigs developed fevers, became
listless, anorexic, and began shivering and huddling together in a
pile. Clinical signs became more severe over the next few days,
with pigs rapidly losing body weight (Fig. 1), becoming dehy-
drated and weak. Respiratory distress, characterized by dyspnea,
tachypnea and coughing was common in all pigs. Erythema of the
skin was present in most of the pigs, and several developed
cutaneous hemorrhages and cyanotic extremities (blue ears)
(Fig. 2). On 7 dpe, one pig from Group 2 was found dead. Two
others were euthanized due to severe weakness and moribund
condition on dpe 8 and 9, and one was found dead on dpe 13.
On 10 and 11 dpe, clinical signs of disease in some of the
HP-PRRSV challenged group began to decrease in severity. Whilepigs remained huddled in a pile with respiratory signs, approxi-
mately half of them were subjectively less listless, would move
away when approached and began showing an interest in feed
again. During the study, contact pigs displayed similar clinical
signs as those challenged with HP-PRRSV . Pigs challenged with
VR-2332 (Group 4) were clinically normal until dpe 7, when they
began to exhibit slightly increased respiratory rates and became a
little less active than the control group. One pig from the VR-2332
group was found dead on dpe 9; however, the cause of death was
attributed to gastric dilatation and volvulus, rather than to clinical
disease typical of PRRSV strain VR-2332 . Control pigs (Group 1)
remained clinically normal for the duration of the study.
Gross pathology
Postmortem examination revealed severe lesions in the HP-
PRRSV challenged pigs including: marked interstitial pneumonia,
lymphadenopathy and thymic atrophy. Necropsy ﬁndings in this
group include: pulmonary edema, pleuritis, peritoneal and peri-
cardial effusions, renal petechia, and ﬁbrinous peritonitis that are
delineated in Table 1. Lungs and representative lesions are shown
in Fig. 2. No pathologic lesions were identiﬁed in control pigs
(Group 1). Pigs in the VR-2332 challenge group (Group 4) had
diffuse interstitial pneumonia, characteristic of an uncomplicated
PRRSV infection. Although lung lesions were subjectively more
severe in the HP-PRRSV and contact groups, a statistically sig-
niﬁcant difference in lung scores was only found between the
rJXwn06 contact group and the group inoculated with VR-2332
(Groups 4 and 3, Po0.003) (Fig. 3A). Lymphadenopathy was
present in all infected pigs (Groups 2–4 ), with no statistically
signiﬁcant difference between HP-PRRSV and VR-2332 infected
groups (Fig. 4A). Thymic atrophy was also a common ﬁnding in
infected pigs and was signiﬁcantly more severe in HP-PRRSV
infected and contact pigs compared to VR-2332 infected pigs
(P¼0.0003 and Po0.0001; Fig. 4B). Table 2 summarizes aspects
of the clinical disease seen in this study.
Fig. 2. Gross pathology. (A) Representative normal lung from a sham inoculated control pig (Group 1). (B) Macroscopic lesions in pigs challenged with HP-PRRSV strain
rJXwn06 (Group 2) were severe and include interstitial pneumonia with consolidation, and pulmonary edema. (C) myocardial necrosis. (D) Contact pigs (Group 3) had
similar lung lesions. (E) Cyanotic extremities and ears (blue ears) were common as shown in the contact pig. (F) Pigs challenged with VR-2332 (Group 4) had lung lesions
characteristic of an uncomplicated PRRSV infection.
Table 1
Macroscopic lesions in treatment groups.
Organ Macroscopic lesions Group 1:
Control
Groups 2–3:
rJXwn06
challenge and
contact
Group 4: VR-
2332 challenge
pigs
Lung
Interstitial
pneumonia
 þ þ
Pulmonary edema  þ 
Infarct/Hemorrhage  þ 
Pleuritis  þ 
Thymus 
Thymic atrophy  þ 
Lymph nodes
Lymphadenopathy  þ þ
Hemorrhage,
Congestion
 þ 
Body cavities
Hydrothorax,
Ascites,
Hydropericaridum
 þ 
Heart
Myocardial
necrosis/
Myocarditis
 þ 
Hemorrhage  þ 
Kidney
Petechiae,
Hemorrhage
 þ 
Integument
Cyanosis  þ 
Periorbital edema  þ 
Other
Serous atrophy of
fat
 þ 
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Microscopic lung lesions consisted of histiocytic interstitial
pneumonia with increased numbers of macrophages in alveolarsepta and lumina (Fig. 5A, C). Type II pneumocyte hyperplasia was
also present. These lesions were seen in the HP- PRRSV challenge
group (Group 2), the HP-PRRSV contact pigs (Group 3) and the
VR-2332 challenge group (Group 4). Mean interstitial pneumonia
lesions were 3.33, 3.75, and 2.00 for Chinese PRRSV challenge
group (Group 2), contact Chinese PRRSV pigs (Group 3) and VR-
2332 challenge (Group 4), respectively (Fig. 3B). Lesions were
signiﬁcantly (P¼0.0002) more severe in the Chinese PRRSV chal-
lenge group (Group 2) and contact Chinese PRRSV pigs (Group 3) as
compared to the VR-2332 challenge (Group 4). Two sham inocu-
lated control pigs had mild lesions with a score of 1, while the
remaining pigs had no lesions. Immunohistochemistry labeling for
PRRSV nucleocapsid was positive in 100% of Chinese PRRSV
challenge and contact pigs (Groups 2 and 3) and 88% of VR-2332
challenge pigs (Group 4), with mean IHC labeling scores of 2.08,
1.75, and 1.63, respectively (Fig. 5). Positive labeling was present in
alveolar macrophages and interstitial macrophages for all infected
groups (Fig. 5B and C). No signiﬁcant difference was present in the
amount of PRRSV labeling in the lung among the three treatment
groups. Immunohistochemistry labeling for PRRSV in lung tissue
was negative in all sham inoculated control pigs.
Serology
Sera collected at 1, 7, and 13 dpe were tested for PRRSV
antibody. Most swine infected with rJXwn06 (Group 2) had
seroconverted by 7 dpe (mean S/P¼0.51, SD¼0.30), and all had
seroconverted by 13 dpe (mean S/P¼1.14, SD¼0.26); however,
the rJXwn06 contact animals (Group 3) had not yet seroconverted
by 5 dpe (mean S/P¼0.00, SD¼0.00) but did by 11 dpe (mean
S/P¼0.99, SD¼0.12). VR-2332 infected pigs (Group 4) were
seronegative at 7 dpe (mean S/P¼0.09, SD¼0.12); but positive
by 13 dpe (mean S/P¼1.05, SD¼0.37). The sham inoculated
control animals (Group 1) remained negative for PRRSV nucleo-
capsid antibody throughout the study.
Virus isolation
All serum and BALF samples were screened on MARC-145 cells
for infectious virus, and VI positive samples were then titered.
Fig. 3. Lung scores and associated signiﬁcance values for all groups. (A) Macroscopic lung scores. (B) Microscopic lung scores.
Fig. 4. (A) Lymph node weight (LNW) to body weight (BW) ratios showed pronounced lymphadenopathy in all infected animals (Groups 2–4) as compared to control
animals (Group 1)(P¼0.02 or higher signiﬁcance), but no statistical signiﬁcance between PRRSV infected swine. (B) Thymus weight (TW) to BW ratios showed thymic
atrophy in all infected animals (Groups 2–4) as compared to control animals (Po0.0001), and statistically signiﬁcant differences between HP-PRRSV inoculated
(Po0.0001) and naturally infected (P¼0.0003) animals compared to VR-2332 inoculated swine.
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challenge and rJXwn06 contact pigs was found in the serum when
compared to the VR-2332 challenge group (Fig. 6A). No signiﬁcant
differences were found in serum virus titer between the rJXwn06
challenge and rJXwn06 contact groups at any time points even
though the contact pigs were exposed to rJXwn06 infected pigs at
2 dpe. At necropsy, no signiﬁcant differences in BALF titers were
found among the rJXwn06 challenge, rJXwn06 contact, or VR-2332
challenge groups (Fig. 6B). Control serum and BALF samples were
VI negative throughout the experiment (Fig. 6A and B).Quantitative real-time RT-PCR (qRT-PCR)
To examine the levels of PRRSV RNA and to strengthen the case
for the apparent difference in viral loads between the HP-PRRSV
and VR-2332 inoculated animals seen above, qRT-PCR was com-
pleted on all serum samples as well as BALF and lymph node
tissue (Fig. 7). The level of viral RNA detected in serum samples
mirrors the results obtained by virus isolation on MARC-145 cells
(Fig. 7A, Pr0.005 at all dpe). The qRT-PCR results from BALF
showed little or no signiﬁcant difference between the infected
B. Guo et al. / Virology 435 (2013) 372–384376groups (Fig. 7B). TBLN samples suggested that swine inoculated
with VR-2332 had signiﬁcantly less viral RNA present than those
inoculated (P¼0.0205) or infected (P¼0.0017) with HP-PRRSV
(Fig. 7C). Sham inoculated control serum, BALF, and TBLN tissue
samples were viral RNA negative throughout the experiment
(Fig. 7A–C ).
Bacterial isolation
Bacteria were isolated from the BALF of 8 of the 12 rJXwn06
inoculated pigs (Group 2) and 2 of the 4 rJXwn06 contact pigs
(Group 3) but from only 1 of 8 pigs in each of the sham inoculated
control (Group 1) and VR-2332 inoculated (Group 4) groups. In
the rJXwn06 challenge group Pasteurella multocida was isolated
from four pigs (ranging from 50 to 4300 CFU/100 mL), P. multo-
cida (4300 CFU/100 mL) and Actinobacillus suis (4300 CFU/
100 mL) were isolated from two pigs, P. multocida, A. suis andTable 2
Summary of clinical disease.
Symptom Chinese Contact VR-2332 Control
Anorexia þþþa þþþ – 
Listlessness þþþ þþþ – 
Dyspnea þþþ þþþ – 
Increased respiration þþþ þþþ þ 
Average weight gain (kg) 0.79 þ7.23 þ5.31
% Lung affected 30.8% 22.6% 0.10%
Thymus atrophy (TW/BW) 0.38 0.73 1.02
Lymph nodes (LNW/BW) 0.23 0.27 0.14
Bacterial load—brain, heart & lungs þþþ þþþ  
Death 4/12 0/4 1b/8 0/6
a Subjective scale whereþþþ is most severe and  is normal.
b Gastric dilatation and volvulus unrelated to PRRSV infection.
Fig. 5. (A) Lung section from a Group 2 pig inoculated with rJXwn06. Severe diffuse h
(asterisks). Alveolar lumina were ﬁlled with alveolar macrophages, neutrophils and n
thickened by histiocytes and vessels were cuffed by perivascular macrophages, lymphoc
pig. Positive cytoplasmic PRRSV labeling was seen in alveolar macrophages, inter
Immunoperoxidase-DAB, hematoxylin counterstain. (C) Lung section from a Group 4
pneumonia. Alveolar septa were thickened by histiocytes and alveolar lumina containe
4 strain VR-2332 inoculated pig. Positive cytoplasmic PRRSV labeling was seen in alv
hematoxylin counterstain.Streptococcus suis (approximately 50, 100, and 25 CFU/100 mL,
respectively) from one pig, and Staphylococcus aureus and Klebsiella
pneumoniae (approximately 150 and 20 CFU/100 mL, respectively)
were isolated from one pig. In the contact group, P. multocida and A.
suis were isolated from one pig (4300 CFU/100 mL each) and
P. multocida, A. suis, and Arcanobacterium pyogenes (approximately
50, 4300, and 4300 CFU/100 mL, respectively) were isolated from
a second pig. S. aureus and Escherichia coli (4300 CFU/100 mL each)
were isolated from 1 VR-2332 inoculated pig, and Bordetella
bronchiseptica (65 CFU/100 mL) was isolated from 1 sham inocu-
lated control pig.Effects of PRRSV infection on innate and adaptive immunity cytokine
levels
Results on 10 cytokines measured in serum, BALF and TBLN
homogenates are presented in Figs. 8 and 9 and the changes in
cytokine levels relative to sham-inoculated controls are listed in
Table 3. Pigs directly inoculated with rJXwn06 (Group 2) had
signiﬁcantly elevated average serum levels of IFNa, IL-1 b, IL-2,
IL-10 and IFNg, ranging from 6 to 11 times the levels detected in
sera of sham inoculated controls (Group 1). In pigs inoculated
with rJXwn06, serum IFNa levels were signiﬁcantly elevated at
4 dpe in comparison to both controls and VR-2332 exposed
pigs (Po0.05) and remained signiﬁcantly elevated at 7 dpe
versus both groups. Serum levels of IL-10 were elevated by
7 dpe, with IL-2, IL-10, IL-12 and IFNg all signﬁcantly elevated
at 11 dpe compared to both controls and VR-2332 exposed pigs
(Po0.05). Compared with sham inoculated controls, contact
pigs exposed to rJXwn06 (Group3) developed signiﬁcant serum
level elevations (3 to 89 times greater) in 3 out of 5 innate
immunity cytokines measured (IFNa, TNFa and IL-1 b) andistiocytic and necrotizing interstitial pneumonia with a suppurative bronchiolitis
ecrotic debris; clumps of chromatin (arrows) were present. Alveolar septa were
ytes and plasma cells. 100x. (B) Lung section from a Group 2 HP-PRRSV inoculated
stitial macrophages and macrophages present in the bronchiole lumen. 200x,
pig inoculated with strain VR-2332. Moderate multifocal histiocytic interstitial
d alveolar macrophages and neutrophils. 100x, HE. (D) Lung section from a Group
eolar macrophages and interstitial macrophages. 200x, Immunoperoxidase-DAB,
Fig. 6. Virus titers expressed as 50% of the tissue culture infective dose per ml (TCID50/ml) of sample. (A) Serum samples during the course of the experiment and
(B) Brochoalvealor lavage ﬂuid (BALF) after study termination.
Fig. 7. Quantitative RT-PCR (qRT-PCR) results in copies of PRRSV RNA per ml. A. Serum samples. B. BALF. C. Lymph node samples (LN).
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measured associated with adaptive immunity (IL-2, IL-4, IL-10,
IL-12 and IFNg). In pigs exposed to rJXwn06 by contact transmis-
sion, serum IFNa levels were signifcantly elevated at 2, 5 and
9 dpe in comparison to controls (Po0.05). In addition, contact
pigs had signiﬁcant elevations in IL-1 b at 9 and 11 dpe (Po0.05).
Contact pigs also had signiﬁcantly elevated levels of all adaptive
immunity cytokines at 9 and 11 dpe (Po0.05) with IL-10 also
signiﬁcantly elevated at 5 dpe. In contrast, none of the 10
cytokines measured had signiﬁcant elevations in serum levels
detected in pigs inoculated with the North American prototype
strain VR-2332 (Group 4) when compared with sham inoculated
controls.
Similarly, when compared to sham inoculated controls, BALF
of swine inoculated with rJXwn06 (Group 2) had signiﬁcantly
elevated (7 to 22 times greater) levels of 3 out of 5 innate
immunity cytokines measured (TNFa, IL-1 b and IL-8) and
elevated levels (2 to 54 times greater) for all 5 cytokines mea-
sured associated with adaptive immunity (IL-2, IL-4, IL-10, IL-12
and IFNg). Compared with sham inoculated controls, contact
swine exposed to rJXwn06 (Group 3) had signiﬁcantly elevatedBALF cytokine levels (4 to 21 times greater) in 4 out of 5 innate
immunity cytokines measured (IFNa, TNFa and IL-8) and elevated
levels (3 to 30 times greater) for all 5 cytokines measured
associated with adaptive immunity (IL-2, IL-4, IL-10, IL-12 and
IFNg). In contrast, swine inoculated with VR-2332 (Group 4) had
signiﬁcantly elevated BALF cytokine levels (4 times greater) for
only 2 out of 5 innate immunity cytokines measured (IL-1b and
IL-8) and elevated levels (10 to 12 times greater) for 2 of
5 cytokines measured associated with adaptive immunity (IL-10
and IFNg).Discussion
In this study, we compared the pathogenicity of Chinese
HP-PRRSV strain rJXwn06 to North American prototype VR-2332
in U.S. high health swine under controlled conditions. The clinical
disease induced in this study by the HP-PRRSV virus was similar
to what has been reported in Asia for PHFD and for experimental
infections with the wild-type or rescued virus (Li et al., 2007;
Lv et al., 2008; Tian et al., 2007; Tong et al., 2007; Wu et al., 2009;
Fig. 8. Innate cytokine protein (IFNa, TNFa, IL-1b, IL-6, IL-8) levels in (A) Serum samples at speciﬁed days post exposure, (B) Bronchoalveolar lavage (BALF) at necropsy,
and (C) Tracheobronchial lymph node (TBLN) at necropsy.
B. Guo et al. / Virology 435 (2013) 372–384378Zhou et al., 2009; Zhou et al., 2008). Likewise, the clinical disease
induced by the VR-2332 virus was similar to that observed in
previous reports (Faaberg et al., 2010; Rossow et al., 1994).Clinical disease and pathology were much more severe in the
rJXwn06 group and their contacts than in the VR-2332 group.
Overall, gross pathology lesions in the rJXwn06 challenged and
Fig. 9. Adaptive cytokine protein (IL-2, IL-4, IL-10, IL-12, IFNg) levels in (A) Serum samples at speciﬁed days post exposure, (B) Bronchoalveolar lavage (BALF) at necropsy,
and (C) Tracheobronchial lymph node (TBLN) at necropsy.
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Table 3
Changes in cytokine levels in sampled tissues relative to non-challenged control pigs (P-values in comparison to non-challenged controls). Serum values are an area under
the curve overall average level measured in samples collected after exposure to virus. Geometric means back-calculated from Log10 means were used to determine relative
changes in TBLN and BALF cytokine levels compared to sham-inoculated controls. NS=not signiﬁcant
Change Relative to Controls
Cytokine Serum P BALF P TBLN P
JXwn06 principals Innate IFNa 6.2 X o0.0001 2.4 X NS 9.8 X 0.005
TNFa 3.9 X NS 22.3 X o0.0001 1.0 X NS
IL-1b 9.6 X 0.04 20.1 X o0.0001 2.0 X 0.002
IL-6 1.5 X NS 3.5 X NS 0.9 X NS
IL-8 0.9 X NS 7.4 X o0.0001 3.0 X 0.001
Adaptive IL-2 11.2 X 0.04 4.4 X 0.005 1.2 X NS
IL-4 2.3 X NS 1.8 X o0.03 0.4 X 0.001
IL-10 6.2 X 0.002 24.1 X o0.0001 11.9 X o0.0001
IL-12 1.3 X NS 10.1 X o0.0001 5.0 X o0.0001
IFNg 7.0 X 0.01 53.5 X o0.0001 11.5 X o0.0001
JXwn06 contacts Innate IFNa 89.4 X 0.003 8.0 X 0.007 37.8 X 0.0005
TNFa 3.0 X 0.02 20.6 X o0.0001 2.4 X 0.03
IL-1b 4.7 X 0.05 4.4 X 0.02 3.3 X 0.0001
IL-6 0.2 X NS 4.0 X NS 1.2 X NS
IL-8 0.9 X NS 7.6 X o0.0001 6.0 X o0.0001
Adaptive IL-2 20.8 X 0.0007 4.3 X 0.02 1.3 X NS
IL-4 3.0 X 0.04 3.3 X 0.0004 0.6 X NS
IL-10 5.8 X 0.002 18.3 X o0.0001 26.8 X o0.0001
IL-12 3.6 X 0.004 29.6 X o0.0001 11.6 X o0.0001
IFNg 4.3 X 0.009 25.8 X o0.0001 22.1 X o0.0001
VR2332 principals Innate IFNa 1.4 X NS 1.2 X NS 1.3 X NS
TNFa 1.5 X NS 2.4 X NS 0.9 X NS
IL-1b 1.6 X NS 5.0 X 0.004 1.0 X NS
IL-6 0.04 X NS 0.6 X NS 0.6 X NS
IL-8 0.7 X NS 3.8 X o0.0001 1.4 X NS
Adaptive IL-2 1.6 X NS 1.4 X NS 0.2 X 0.0005
IL-4 1.9 X NS 1.1 X NS 1.7 X 0.04
IL-10 2.0 X NS 10.1 X o0.0001 5.0 X o0.0001
IL-12 1.4 X NS 1.2 X NS 1.0 X NS
IFNg 2.8 X NS 12.0 X o0001 2.9 X 0.001
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solely to the respiratory tract and lymph nodes as was the case
with the VR-2332 challenged pigs. The high occurrence of
bacterial co-infections in the rJXwn06 challenge and contact
swine likely played a prominent role in the difference in pathol-
ogy and clinical disease between groups. Bacterial co-infections in
pigs naturally infected with PRRSV have been documented, with
susceptibility attributed to factors including PRRSV strain differ-
ences, host genetics, management practices and environmental
factors (Rossow, 1998). In this study, we used swine of high
health status in a controlled research environment that were from
2- and 3-way crosses of commercial genetic lines. We believe the
incidence and magnitude of bacteria isolated from the rJXwn06
challenge and contact groups when compared to the VR-2332 and
control groups suggest the differences in secondary bacterial
infection susceptibility are speciﬁc to viral strain. In this study,
we observed a 30% mortality rate in rJXwn06 infected pigs by
13 dpe, which is less mortality than the original report (Zhou
et al., 2009), but similar to other HP-PRRSV strains used (Li et al.,
2007; Lv et al., 2008; Zhou et al., 2008). Possible explanations for
differences may be the route and dose of inoculation, the age of
pigs, the HP-PRRSV strain utilized, and the time course of study. In
addition, since the HP-PRRSV lineage may exacerbate subclinical
bacterial infections, it is possible different endemic bacterial
infections played a role in apparent different mortality rates.
In natural infections with Chinese HP-PRRSV, pulmonary
interstitial hyperplasia with hemorrhage and edema is described,
which suggests an acute septicemic process due to a secondary
bacterial pathogen (Tian et al., 2007; Zhou and Yang, 2010). Upon
histopathologic examination of tissues from this study, North
American pigs directly inoculated with rJXwn06, as well ascontact pigs, had an interstitial pneumonia that was signiﬁcantly
more severe than the VR-2332 inoculated group, which is con-
sistent with the severity of disease reported in China. Although
pulmonary lesions were more severe in the rJXwn06 challenge
and contact pigs, the amount of antigen labeling was not
signiﬁcantly different from the VR-2332 inoculated swine. Since
levels of proinﬂammatory cytokines, including TNFa, IL-1 b and
IL-8, were signiﬁcantly increased in the BALF of rJXwn06-inoculated
and contact pigs, the host response to HP-PRRSV may play a role in
the augmented lung pathology seen. In addition, the increased
incidence of secondary bacterial infections in rJXwn06 challenge
and contact pigs may have contributed to increased cytokine
production and resultant immunopathology.
There are numerous reports about the interplay of PRRSV with
the swine immune system that describe variable responses to
infection at the cellular and cytokine level (Miguel et al., 2010;
Thanawongnuwech et al., 2004; Thanawongnuwech and Thacker,
2003; Wang et al., 2011). Although a large part of this variability
may result from differing methods, challenge viruses, outbred
pigs, and experimental designs, there are consistent ﬁndings
emerging among the studies of increases in levels of selected
cytokines associated with both innate and adaptive immunity.
Here we report a comprehensive assessment of the effects of
PRRSV infection on levels of cytokines critical to innate (IFNa/b,
TNFa, IL-1 b, IL6 and IL-8) and adaptive (IL-2, IL-4, IL-10, IL-12 and
IFNg) immune systems in serum, BALF and TBLN homogenates. It
was demonstrated that infection with a highly pathogenic strain
of PRRSV elicited a signiﬁcant elevation of all adaptive immunity
cytokines measured in BALF, as well as a majority of these
cytokines in serum and TBLN homogenates of the same groups
of pigs. This observation is consistent with previous reports of
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infected with PRRSV (Lemke et al., 2004). Swine infected here
with VR-2332 and previous studies with other viral strains found
that PRRSV infections are associated with delayed or failed
production of detectable serum IFNa levels (Diaz et al., 2005;
Gomez-Laguna et al., 2010a; Gomez-Laguna et al., 2010b). Pre-
vious studies indicate that PRRSV inhibits IFN-induced JAK/STAT
signaling, thus possibly accounting for the delayed or inadequate
IFNa response by the host [reviewed in (Sun et al., 2012)]. In
contrast, in pigs infected in this study with rJXwn06, we observed
signiﬁcant elevations of serum IFNa as the ﬁrst cytokine to peak
following exposure to rJXwn06 in either the directly challenged or
contact pigs, with the zenith occurring 4 and 2 dpe, respectively.
However, consistent with a previous study (Gomez-Laguna et al.,
2009), elevated serum IFNa had little to no apparent effect on
virus clearance as the viremia peaked in the rJXwn06 challenge
and contact pigs on dpe 7 and 4, respectively, and remained above
the serum virus levels of VR-2332 pigs until the end of the study
(11 and 13 dpe). It is well documented that PRRSV infection will
increase the susceptibility of swine to co-infection with various
bacteria (Brockmeier et al., 2001; Thanawongnuwech et al., 2004;
Thanawongnuwech and Thacker, 2003; Thanawongnuwech et al.,
1997; Thanawongnuwech et al., 2001; Xu et al., 2010), and based
on previous ﬁndings with other HP-PRRSV strains (Xu et al., 2010)
and our current rJXwn06 ﬁndings, it is clear that exposure to
HP-PRRSV greatly increases the likelihood of secondary bacterial
infection due to commensal or pathogenic organisms typically
found in the swine upper respiratory tract. Whether the signiﬁ-
cant elevations of multiple cytokines that were measured in
serum, BALF and TBLN following exposure to rJXwn06 were a
direct result of the virus, an indirect effect mediated by the
secondary bacterial infections, from extensive host tissue damage,
or a combination of all of these events cannot be determined from
our experiments. However, the pattern of multiple cytokines
being elevated nearly simultaneously in serum (8 of 10 cytokines
in rJXwn06 contact pigs and 5 of 10 cytokines in direct inoculated
pigs) has not previously been reported and was not detected in
VR-2332 infected swine.
Cytokines are a diverse collection of peptides that elicit a wide
range of biological responses and are characteristically understood
in the context of an immune response wherein inﬂammation and
immunity are carefully orchestrated by sequential secretion of
cytokines that coordinate innate and adaptive immune responses.
Macrophages and stressed or damaged cells typically initiate a
cytokine cascade through secretion of chemokines and proinﬂam-
matory cytokines in order to initiate the innate immune response at
sites of acute infection or damage. Generally, they act locally at
nano- to picogram levels with short half-lives and transient activity.
However, inﬂammatory cytokine cascades classically comprise a
sequential appearance and disappearance of proinﬂammatory cyto-
kines (e.g., TNFa, IL-1 and IL-6) intended to activate immune cells
and their recruitment to generate additional cytokines and chemo-
kines. This initial wave of cytokine production is usually followed by
anti-inﬂammatory cytokine production (mainly the IL-10 family) to
moderate or down regulate the pro-inﬂammatory cytokines. Cyto-
kine cascades are therefore usually sequential with transiently
detectable levels in peripheral blood; any dysregulation of these
cascades can lead to adverse immunopathological responses.
While signiﬁcant elevations of several cytokine levels in
tissues such as BALF and TBLN were expected, near simultaneous
elevation of several cytokines in serum was not entirely expected
as part of a normal host immune response. Moreover, the levels of
cytokines detected were in several instances signiﬁcantly ele-
vated (usually several times more) over levels detected with the
low virulence North American prototype PRRSV strain, VR-2332 .
Prolonged elevations of serum IFNg levels have been reported inswine infected with PRRSV, a ﬁnding in contrast to serum IFNg in
pigs infected with inﬂuenza or respiratory coronavirus, where
minimal transient detectable levels are observed (Wesley et al.,
2006).
In swine infected with rJXwn06, it appears the normal
sequence of cytokine production (e.g., IFNg, TNFa, and IL-2 often
being the ﬁrst cytokines produced in response to a viral infection,
followed by IL-6 and IL-10) leading to effective virus clearance
and a normal immune response was dysregulated given that
signiﬁcant elevations of several serum cytokines levels were still
evident at 7 to 11 dpe. Two recent studies have reported
HP-PRRSV infection in swine results in down regulation of a key
toll-like receptor adapter gene, SARM1 (sterile a- and armadillo-
motif-containing protein) (Zhou et al., 2011; Zhou et al., 2012).
SARM1 normally dampens the proinﬂammatory immune
response by attenuating NF-kB activation and decreasing expres-
sion of IL1, IL-8 and TNFa (Carty et al., 2006). Previous studies in
pigs infected with strains of HP-PRRSV were reported to have
swollen livers and petechial hemorrhages on the kidneys as well
as immunohistochemical staining evidence of viral antigen in the
liver and kidneys (among other tissues)(Li et al., 2007; Tian et al.,
2007). Impaired hepatic and renal function as a consequence of
viral or secondary bacterial disease could have a signiﬁcant effect
on clearance of the cytokines detected in serum, and contribute to
an apparent severe cytokine release syndrome.
Whether our ﬁndings represent a parallel condition in swine to
severe cytokine release syndromes or cytokine storms reported in
humans that have been attributed to various causes cannot be
proven with our data (Descotes and Gouraud, 2008; Tarrant,
2010). However, given PRRSV causes polyclonal B cell activation,
autoimmunity, lymphoid hyperplasia and hypergammaglobuline-
mia in pigs (Lemke et al., 2004), and it modulates multiple
intracellular signaling pathways [reviewed in (Sun et al., 2012)],
it is not surprising to ﬁnd an exaggerated immune stimulation in
swine infected with a particularly virulent strain of PRRSV. Early
studies with cytokine administration to livestock species identi-
ﬁed potential toxicities associated with systemic cytokine admin-
istration. Interferon-g was found to have beneﬁcial activity on
immune function but was too toxic for practical usage due to
febrile responses observed within 24 h of a single dose of 1.25 mg/
kg of body weight (Roth and Frank, 1989). Similarly, administra-
tion of 166 ng of bovine IL-1 b/kg of body weight every 8 h for
4 days caused transient fever, inappetence, increased pulse and
respiratory rate, and diuresis (Goff et al., 1992). Blood cytokines
have been proposed as biomarkers of in vivo toxicity associated
with new drug development (Tarrant, 2010). Under most disease
scenarios where there is rapid resolution of the infection by the
host immune response, much of the biological activity of cyto-
kines will occur in the locally infected tissues and elevated levels
of the cytokines may not be detected in serum.
We cannot deﬁnitively state whether the elevated cytokine
syndrome reported here contributes to the pathophysiology of
the disease caused by this highly pathogenic PRRSV isolate.
However, the association between the elevated levels of multiple
cytokines and the severe morbidity and high mortality reported is
consistent with a multiple cytokine toxicity syndrome in humans
associated with various therapeutics (Tarrant, 2010). Adverse
reactions ranging from mild-to-moderate ﬂu-like reactions to
severe cytokine release syndromes have been observed with
many therapeutic proteins in current use in human medicine,
and some result in severe and even potentially life-threatening
syndromes (reviewed in (Tarrant, 2010)). Macrophage activation
syndrome and cytokine storm are different names for two
syndromes that share many features including a massive inﬂam-
matory response, elevated serum cytokine levels, multiorgan
system disease and often death (Behrens et al., 2011). Although
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kines that predominate in each may differ with TNFa being
dominant in bacterial sepsis and IFNg predominate in the macro-
phage activation syndrome (Behrens et al., 2011). The exact
pathophysiology of the systemic toxicity in these syndromes is
not fully deﬁned. In pigs infected by natural contact with rJXwn06
inoculated pigs, we detected signiﬁcant serum elevations in IFNa,
TNFa, IL-1 b, IL-2, IL-4, IL-10, IL-12 and IFNg. However, given that
PRRSV infects the macrophage cell line in pigs, the elevated serum
cytokine levels in pigs infected with HP-PRRSV may represent
both conditions (macrophage activation syndrome and cytokine
storm) and contribute to the multiorgan damage and high
mortality reported here.Materials and methods
Cells and viruses
MARC-145 cells were cultured in minimum essential medium
(MEM, SAFC 56416C) with 10% fetal bovine serum at 37 1C, 5%
CO2. Wild-type (wt) Type 2 PRRSV strain VR-2332 (GenBank
U87392), passage 6 on MARC-145 cells, was titrated, and used
for the swine study. Virus (rescued rJXwn06; rJXwn06) was
rescued from a cloned cDNA of Chinese highly pathogenic Type
2 PRRSV strain JXwn06 in MARC-145 cells [pWSK-JXwn; GenBank
EF641008, (Zhou et al., 2009)] and passaged 3 times on MARC-145
cells for use in the swine study.
Swine study
The in vivo swine study described here was performed at the
National Animal Disease Center under approval from its Animal
Care and Use Committee. Thirty-two 10-week-old cross-bred pigs
were obtained from a U.S. high-health status herd and were found
to be free of PRRSV antibodies by HerdChek ELISA, inﬂuenza virus
antibodies by NP ELISA, and negative for porcine circovirus type
2 by quantitative real-time PCR (data not shown). One day prior
to inoculation, pigs were bled, weighed and randomly assigned to
one of four groups. Group 1 (N¼8) consisted of sham inoculated
control pigs, which received an intranasal 2 ml sham inoculum of
MEM on day 0. Group 2 pigs (N¼12) were challenged intranasally
with 2 ml of 1106 50% tissue culture infective dose (TCID50)/ml
of Chinese PRRSV strain rJXwn06 in animal Biosafety Level 3-
Agriculture (BSL3-Ag) housing, where they remained for the
duration of the experiment. Group 3 consisted of naı¨ve pigs
(N¼4) that were placed in contact with Group 2 two days after
Group 2 was inoculated (dpe). Group 4 pigs (N¼8) were chal-
lenged intranasally on day 0 dpe with 2 ml of 1106 TCID50/ml of
Type 2 prototype strain VR-2332 . Groups 1 and 4 were housed in
separate isolation rooms in an ABSL2 facility.
Clinical and pathological examinations
Clinical monitoring of pigs was performed daily throughout
the study. Speciﬁcally, observations were made regarding the
pig’s mental alertness, body condition, appetite, activity level, and
clinical signs of respiratory or systemic disease. Serum was
collected on 1, 4, 7, 11, and 13 dpe (sera from Group 3 pigs
was collected on 3, 2, 5, 9 and 11 dpe), and pigs were weighed
on 1, 7 and 13 dpe (Group 3 were weighed on 3, 5 and
11 dpe). Necropsy was scheduled on dpe 13 (dpe 11 for Group 3),
or sooner if pigs died or were euthanized due to severe disease. At
necropsy, a thorough post-mortem examination was performed,
and a complete set of samples was collected for evaluating
disease severity. Tracheobronchial lymph nodes (TBLN) andthymic tissue were weighed (LNW and TW, respectively) and
compared to respective body weights (BW) to derive a tissue
mass index (LNW/BW, TW/BW) measuring the effect of PRRSV
infection on organ weight (Mengeling et al., 2003). Upon removal,
lungs were examined and extent of macroscopic lung lesions was
estimated, as previously described, and reported as a percentage
of lungs affected (Halbur et al., 1996). Sections of tissues (lung,
tracheobronchial lymph node, trachea, thymus, heart, tonsil,
spleen, iliac lymph node, mesenteric lymph nodes, ileum, bone
marrow, kidneys, liver, inguinal lymph node, cerebrum, brain-
stem, cerebellum and ventral midbrain) were collected into 10%
neutral-buffered formalin for histopathology and immunohisto-
chemistry. TBLN were collected for RNA extraction and cytokine
protein assays. Bronchoalveolar lavage ﬂuid (BALF) was collected
after removing whole lungs from pigs and aseptically lavaging
with 50 ml antibiotic-free MEM.
Microscopic lesions
Tissues were processed by routine histopathologic procedures
and slides were stained with hematoxylin and eosin. A board-
certiﬁed veterinary pathologist blinded to treatment groups
evaluated microscopic lesions. Lung sections were scored on a
5-point scale that accounted for distribution and severity of
interstitial pneumonia: 0-No Lesions, 1-Mild, focal to multifocal
interstitial pneumonia (o50% of lung section affected), 2-Mod-
erate, multifocal to coalescing (50–75% of lung section affected),
3-Severe, patchy to coalescing and extensive (75–90% of lung
section affected), and 4-Severe and diffuse (490% of lung section
affected).
Immunohistochemistry
PRRSV-speciﬁc antigen was detected in lung tissues using a
previously described immunohistochemical (IHC) method with
minor modiﬁcations (Halbur et al., 1995). Brieﬂy, tissue sections
were deparafﬁnized and hydrated in distilled water. Slides were
quenched in 3% hydrogen peroxide for 10 min, rinsed three times
in distilled water and treated in 0.05% protease for 2 min. Slides
were then rinsed three times in distilled water. A primary
monoclonal antibody (MAb) cocktail of one part 1:800 PRRSV
SDOW17 (RTI, Brookings, SD) and one part 1:500 PRRSV SR30
(RTI, Brookings, SD) was applied to the slides and were incubated
at room temperature for 1 h. Bound MAbs were stained with
peroxidase-labeled anti-mouse IgG followed by chromogen using
the DAKO LSAB2-HRP Detection System (DAKO, Carpinteria, CA)
according to the manufacturer’s instructions. 3,30-diaminobenzi-
dine (DAB; Vector Laboratories, Burlingame, CA) was applied to
the slides for 5 min. The slides were rinsed in deionized water and
counterstained with Gill’s hematoxylin. PRRSV labeling was
graded on a 4 point scale of 0: None, 1: Mild scattered signals
(1 to 20 cells in entire section), 2: Moderate scattered signals (less
than or equal to 50% of high power ﬁelds (hpf) containing
immunolabeling) and 3: Abundant scattered signals (greater than
50% of hpf contain labeling and/or there are at least 2–3 groups of
30 cells or more with staining).
Virus isolation
Virus isolation was attempted on all serum and BALF samples
as described previously (Faaberg et al., 2010). Those samples that
were positive by virus isolation were then titered by serial
dilution on MARC-145 cells to determine the quantity of virus
present to produce a cytopathic effect in 50% of inoculated tissue
culture cells (TCID50).
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Quantitative RT-PCR (qRT-PCR), as previously described
(Faaberg et al., 2010), was used to determine the amount of viral
RNA per ml of serum and BALF, and per gram of TBLN homo-
genized tissue prepared as described below.Serology
Serum samples were tested on study days 1, 7 and 13 for
evidence of seroconversion with the PRRS 2XR enzyme-linked
immunosorbent assay (HerdChek ELISA; IDEXX Laboratories). A
sample was considered positive for antibodies to PRRSV nucleo-
capsid protein if the sample-to-positive (S/P) ratio was equal to or
greater than 0.4.Cytokine assays
Levels of TNFa, IL-1 b, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70 and
IFNg cytokine levels (pg/ml) were measured in serum, BALF and
TBLN samples diluted 1:2 with dilution buffer supplied by the
manufacturer using a SearchLight (Aushon BioSystems, Woburn,
MA, USA) customized multiplex immunoassay (M-ELISA) following
the manufacturer’s protocol. M-ELISA samples were assayed in
duplicate. The ELISA limits of detection for TNFa, IL-1 b, IL-2, IL-4,
IL-6, IL-8, IL-10, IL-12p70 and IFNg were 0.2, 2.4, 0.78, 0.39, 1.6,
0.098, 0.001, 0.098, and 0.78 pg/ml respectively. Approximately 1 g
of TBLN was homogenized in 750 ml of lysis buffer containing 0.5%
Triton X-100, 150 mM NaCl, 15 mM Tris, 1 mM CaCl2, and 1 mM
MgCl2, pH 7.4, using a tissue homogenizer (Biospec Products,
Bartlesville, OK) (Greenberger et al., 1995). Homogenates were
incubated on ice for 30 min, then centrifuged at 1258 X g for
10 min. Supernatants were collected, passed through a 0.45-
micron ﬁlter (Gelman Sciences, Ann Arbor, MI), then stored at
20 1C prior to assessment of cytokine levels.IFNa enzyme-linked immunosorbent assay (ELISA)
IFNa protein was measured with a porcine IFNa speciﬁc ELISA
by using F17 monoclonal antibody (MAb) and K9 MAb (R&D
Systems Inc.) as previously described (Miller et al., 2009). MAb K9
was conjugated with horseradish peroxidase (HRP) using a
peroxidase labeling kit (Roche Molecular Biochemical, Indianapo-
lis, IN). Immulux HB ﬂat-bottomed 96-well plates (Dynex Tech-
nology, Chantilly, VA) were coated overnight at 4 1C with F17 at a
concentration of 3 mg/plate in coating buffer (100 mM carbonate
buffer, pH 9.6, Sigma Inc., St. Louis, MO). After blocking with 1%
non-fat dried milk, 0.05% Tween 20 in phosphate buffered saline
(PBS) for 1 h at 37 1C, the plates were washed three times with
0.05% Tween 20 in PBS. Samples (50 ml) were added into each well
containing 50 ml of 1% non-fat dried milk, 0.05% Tween 20 in PBS
and incubated for 2 h at 37 1C. Following three washes, 100 ml of
peroxidase conjugated K9 was added to each well. After 1 h
incubation, at 37 1C, and three washes, 100 ml of substrate solu-
tion, tetramethylbenzidine (KPL Inc., Gaithersburg, MD), was
added to each well. After 30 min, the reaction was stopped with
tetramethylbenzidine stop solution (KPL Inc., Gaithersburg, MD)
and the optical density was measured at 450 nm by an ELISA plate
reader. Quantiﬁed recombinant porcine IFNa (rIFNa, R&D Sys-
tems Inc., Minneapolis, MN) was used as a standard, and IFNa
concentrations were calculated based upon a standard curve. One
unit/ml of rIFNa is equivalent to 26 pg/ml.Bacterial assays
Bacterial culture was performed by plating 100 ml of BALF both
on a Casman’s agar plate supplemented with 0.01% nicotinamide
adenine dinucleotide (NAD) and 5% horse serum, and on a 5%
sheep’s blood agar plate. Both agar plates were incubated for 48 h
at 37 1C. Bacterial identiﬁcation was performed by 16S rRNA-
speciﬁc PCR and DNA sequencing.
16S rRNA-speciﬁc PCR and DNA sequencing
Whole-cell bacterial lysates, used as templates, were prepared
by suspending a colony, 2 mm in diameter or the equivalent, in
50 ml of sterile water. The mixture was boiled for 10 min, placed
on ice until chilled, and centrifuged at 16,000 g for 1 min to
pellet cell debris and stored at 20 1C. Supernatant (5 ml) was
used as the template in each PCR. The forward primer (50–
AGAGTTTGATCCTGGCTCAG-30), designated univ16S-3, is homo-
logous to a highly conserved sequence from the 50 end of the 16S
rRNA gene and the reverse primer (50–GCGGCTGCTGGCACG-30),
designated univ16S-4, is homologous to a highly conserved
sequence between the third and fourth variable regions of the
16S rRNA gene. This previously described primer set generates an
amplicon of approximately 520 bp (Register and Yersin, 2005).
Reactions were carried out in a volume of 50 ml and contained 2 U
AmpliTaq polymerase (Applied Biosystems, Foster City, CA), 5 ml
10x buffer II (100 mM Tris–HCl , pH 8.3, 500 mM KCl), 5 ml
dimethyl sulfoxide, 1.5 mM MgCl2, 0.5 mM primers, and 200 mM
deoxynucleoside triphosphates. An initial denaturation step of
5 min at 95 1C was followed by 35 cycles of 20 s at 94 1C, 30 s at
55 1C, and 3 min at 72 1C, with a ﬁnal extension step of 10 min at
72 1C. 10 ml of each PCR was analyzed by agarose gel electrophor-
esis and PCR products were puriﬁed with spin columns (Promega,
Madison, WI) and sequenced directly by ﬂuorescence-based cycle
sequencing with AmpliTaq and BigDye Terminators on an ABI 377
sequencer at the National Animal Disease Center Genomics Unit.
Sequences were analyzed using Geneious 5.0 software (Biomat-
ters Ltd, Auckland, New Zealand).
Data analysis
Quantitative virus copy numbers and serum cytokine levels
were analyzed using a mixed linear model for repeated measures
(Proc Mixed, SAS 9.2 for Windows, SAS Institute, Cary, NC, USA).
Linear combinations of the least squares means estimates for each
variable were used in a priori contrasts after testing for either a
signiﬁcant (Po0.05) effect of PRRSV challenge strain (VR-2332,
rJXwn06, rJXwn06 contacts or sham inoculated controls). Com-
parisons were made between groups at each time-point using a
5% level of signiﬁcance (Po0.05) to assess statistical differences.
Log10 transformed virus copy numbers and cytokine levels in
BALF and TBLN homogenates were analyzed by analysis of
variance using a general linear model for unbalanced data (Proc
GLM, SAS 9.2 for Windows, SAS Institute, Cary, NC, USA). A 5%
level of signiﬁcance (Po0.05) was used to assess statistical
differences. Geometric mean back transformations were made
for ﬁnal data presentation in ﬁgures and tables.Disclaimer
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